Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Maxim Group Downgrades VistaGen Therapeutics to Hold

Maxim Group Downgrades VistaGen Therapeutics to Hold

Maxim Group analyst Jason McCarthy downgrades VistaGen Therapeutics (NASDAQ:VTGN) from Buy to Hold.

byBenzinga Newsdesk

July 26, 2022

1 minute read

Maxim Group analyst Jason McCarthy downgrades VistaGen Therapeutics (NASDAQ:VTGN) from Buy to Hold.

These Analysts Slash Their Forecasts On Nextracker After Q4 Results

By Avi Kapoor

May 15, 1:33 PM

Nextracker Inc. (NASDAQ:NXT) reported better-than-expected fourth-quarter financial results on Tuesday. NEXTracker posted quarterly earnings of 96 cents per…

NXT

Goldman Sachs And A Tech Giant With A Consensus Buy Rating Featured On CNBC’s ‘Final Trades’

By Priya Nigam

April 24, 8:24 AM

On CNBC’s "Halftime Report Final Trades," Stephen Weiss of Short Hills Capital Partners named the U.S. 2 Year Treasury as his final trade.

Tesla, Amazon, Polestar, Nordstrom, Autodesk: Why These 5 Stocks Are Drawing Investors’ Attention Today

By Bhavik Nair

November 22, 9:24 PM

Major Wall Street indices closed over 1% higher on Tuesday after investor focus shifted toward upbeat earnings reports and the possibility of the U.S. Federal Reserve going easy on rate hikes in the future.

ADSK